FindTrial
Sign In

Impact of Adjuvant Therapy on Resected Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Korean Nationwide Study

Role of adjuvant therapy in resected invasive intraductal papillary mucinous neoplasm of the pancreas after surgical resection: Korean multicenter study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010528
Enrollment
700
Registered
2025-05-26
Start date
2022-06-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Patients who underwent surgery between November 1, 2005, and December 31, 2020. ? Patients diagnosed with invasive intraductal papillary mucinous neoplasm (IPMN) during the same period who underwent surgical resection, such as pancreaticoduodenectomy or distal pancreatectomy, followed by adjuvant chemotherapy and/or radiotherapy. ? Patients with at least 12 months of postoperative follow-up. ? Patients with available radiological, pathological, and surgical data.

Exclusion criteria

Exclusion criteria: ? Patients found to have distant metastasis or unresectable invasive intraductal papillary mucinous neoplasm (IPMN) during surgery (i.e., those who underwent palliative surgery). ? Patients with suspected peritoneal seeding. ? Patients with unclear or unknown adjuvant treatment status. ? Patients with incomplete or missing follow-up data.

Design outcomes

Primary

MeasureTime frame
Comparison of survival rates by stage in invasive intraductal papillary mucinous neoplasm—

Secondary

MeasureTime frame
Prognostic factors of invasive intraductal papillary mucinous neoplasm;Indications for adjuvant therapy in invasive intraductal papillary mucinous neoplasm—

Countries

Korea, Republic of

Contacts

Public ContactMunseok Choi

Yonsei University Yongin Severance Hospital

cms2598@yuhs.ac+82-31-5189-8537

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026